The Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures (OPHEMC) within the Office of Public Health Emergency Preparedness (OPHEP) and the Centers for Disease Control and Prevention (CDC) are supporting advanced development of clinical diagnostic point-of-care products for human influenza that meet clinical and public health needs. Developers of these clinical diagnostic products will require availability of laboratories to provide an independent analytical evaluation of the design of their prototype product(s) to support feasibility for further advanced development (e.g., clinical performance evaluation). Highly pathogenic avian influenza virus samples and other biological samples will be used in these evaluations. Any work with live wild-type highly pathogenic influenza H5N1 viruses must be conducted in a USDA-approved Biosafety Level 3 enhanced containment facility (http://www.cdc.gov/flu/h2n2bsl3.htm). Contractor will develop testing protocols, receive prototype influenza point-of-care diagnostic tests and influenza virus samples for use in testing, prepare samples and verify characterization as needed, perform testing with the candidate diagnostic test products, and document, analyze, and report findings. Funding for a firm-fixed-price service type contract will be provided to support this effort. RFP 2007-N-09210 will be available on or about January 2, 2007. The solicitation can be accessed through the internet at http://www.fbo.gov. Any amendments issued to the solicitation will also be made available at the same website. It is the Contractor's responsibility to keep up with additional postings regarding this RFP on the FedBizOpps website. Full and open competition will be used in soliciting offers for this requirement. This procurement is not set-aside for small business. All responsible sources may submit a proposal, which will be considered by the Agency.

Bid Protests Not Available